Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Äèñêóññèîííûå ôîðóìû > Ðàçíîå

Ðàçíîå Ëþáûå ñîîáùåíèÿ íà ìåäèöèíñêèå òåìû, ïî êîòîðûì íåò îòäåëüíûõ ôîðóìîâ. Ôîðóì: ×àñòíàÿ ïðàêòèêà.

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #496  
Ñòàðûé 20.12.2013, 20:22
aberzoy aberzoy âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 03.02.2003
Ãîðîä: Îäåññà
Ñîîáùåíèé: 5,681
Ïîáëàãîäàðèëè 1,128 ðàç(à) çà 1,080 ñîîáùåíèé
aberzoy ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaberzoy ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaberzoy ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaberzoy ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaberzoy ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaberzoy ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaberzoy ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaberzoy ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaberzoy ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaberzoy ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåaberzoy ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Fantique Ïîñìîòðåòü ñîîáùåíèå
Ring study èëè ring trial - ìåòîä èññëåäîâàíèÿ òî÷íîñòè (ïðàâèëüíîñòè è ïðåöèçèîííîñòè) èçìåðåíèÿ êàêîãî-ëèáî ïàðàìåòðà
ñïàñèáî çà ïîÿñíåíèå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #497  
Ñòàðûé 07.01.2014, 10:24
Iera Iera âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 28.01.2010
Ãîðîä: Áàêó
Ñîîáùåíèé: 226
Ñêàçàë(à) ñïàñèáî: 45
Ïîáëàãîäàðèëè 9 ðàç(à) çà 4 ñîîáùåíèé
Iera ýòîò ó÷àñòíèê èìååò õîðîøóþ ðåïóòàöèþ íà ôîðóìå
Êàê ïðàâèëüíî ïåðåâåñòè Life course epidemiology, the Medical Research Council Life course Epidemiology Unit (MRC LEU)

Ñïàñèáî!
Îòâåòèòü ñ öèòèðîâàíèåì
  #498  
Ñòàðûé 07.01.2014, 11:43
Samitin Samitin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.08.2009
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 2,224
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 765 ðàç(à) çà 691 ñîîáùåíèé
Samitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïðÿìîãî ïåðåâîäà, ïîõîæå, íåò ( òî÷íåå, ÿ åãî íàéòè íå ìîãó), õîòÿ ïîäõîä äîâîëüíî íåíîâûé.

Ìîæåò áûòü, "... îòäåëåíèå ýïèäåìèîëîãèè ôèçè÷åñêèõ è ñîöèàëüíûõ ôàêòîðîâ æèçíåííîãî öèêëà..." (îñíîâûâàÿñü íà îïðåäåëåíèè èç ([Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ])?
Èëè, åñëè óæ íà òî ïîøëî, ïðîñòî "... ýïèäåìèîëîãèè æèçíåííîãî öèêëà"? Âñ¸ ðàâíî â ñêîáêàõ ïðèä¸òñÿ àíãëèéñêèé òåðìèí ïðèâîäèòü.
Îòâåòèòü ñ öèòèðîâàíèåì
  #499  
Ñòàðûé 07.01.2014, 11:48
Fantique Fantique âíå ôîðóìà Ïîë ìóæñêîé
Ñåðôåð
 
Ðåãèñòðàöèÿ: 03.04.2009
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 6
Ñêàçàë(à) ñïàñèáî: 2
Ïîáëàãîäàðèëè 1 ðàç çà 1 ñîîáùåíèå
Fantique *
Óñòîÿâøåãîñÿ ïåðåâîäà äëÿ Life course epidemiology íåò, òàê êàê ñàìî ïîíÿòèå â àíãëèéñêîì ÿçûêå ïîÿâèëîñü îòíîñèòåëüíî íåäàâíî. Òàê ÷òî ïðèä¸òñÿ äàâàòü îïèñàòåëüíûé ïåðåâîä, îñíîâûâàÿñü íà îïðåäåëåíèè:
Öèòàòà:
We have defined a life course approach to chronic disease epidemiology as the study of long-term effects on chronic disease risk of physical and social exposures during gestation, childhood, adolescence, young adulthood and later adult life. It includes studies of the biological, behavioural and psychosocial pathways that operate across an individual's life course, as well as across generations, to influence the development of chronic diseases.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Öèòàòà:
We have previously defined life course epidemiology as the study of long term effects on later health or disease risk of physical or social exposures during gestation, childhood, adolescence, young adulthood and later adult life.
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Ñêîðåå âñåãî, ñ òå÷åíèåì âðåìåíè âûðàñòåò î÷åðåäíîé ñêàëüêèðîâàííûé òåðìèí "Ýïèäåìèîëîãèÿ ïðîäîëæèòåëüíîñòè æèçíè" èëè ÷òî-íèáóäü òàêîå æå óæàñíîå.
Ìîæåò áûòü, èñïîëüçîâàòü ÷òî-òî âðîäå "ýïèäåìèîëîãèÿ îòäàë¸ííûõ ïîñëåäñòâèé", çäåñü õîòÿ áû ìîæíî ïîíÿòü, ïðî ÷òî áûë îðèãèíàëüíûé òåðìèí.
Îòâåòèòü ñ öèòèðîâàíèåì
  #500  
Ñòàðûé 09.03.2014, 00:28
Iera Iera âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 28.01.2010
Ãîðîä: Áàêó
Ñîîáùåíèé: 226
Ñêàçàë(à) ñïàñèáî: 45
Ïîáëàãîäàðèëè 9 ðàç(à) çà 4 ñîîáùåíèé
Iera ýòîò ó÷àñòíèê èìååò õîðîøóþ ðåïóòàöèþ íà ôîðóìå
Ìíîãî òåðìèíîâ ïî ãåíåòèêå ïîýòîìó íå î÷åíü ïîíÿòíî. Áóäó áëàãîäàðíà çà ïîìîùü!

Using hybridization probes designed to capture a 6 Mb region flanking CYP21A2, targeted massively parallel sequencing (MPS) was performed to analyze genomic DNA samples from parents and proband to determine parental haplotypes. Plasma DNA from pregnant mothers also underwent targeted MPS to deduce fetal inheritance of parental haplotypes.
Îòâåòèòü ñ öèòèðîâàíèåì
  #501  
Ñòàðûé 17.03.2014, 19:45
Iera Iera âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 28.01.2010
Ãîðîä: Áàêó
Ñîîáùåíèé: 226
Ñêàçàë(à) ñïàñèáî: 45
Ïîáëàãîäàðèëè 9 ðàç(à) çà 4 ñîîáùåíèé
Iera ýòîò ó÷àñòíèê èìååò õîðîøóþ ðåïóòàöèþ íà ôîðóìå
Íèêòî íå ìîæåò ìíå ïîìî÷ü?(
Îòâåòèòü ñ öèòèðîâàíèåì
  #502  
Ñòàðûé 18.03.2014, 12:02
Àâàòàð äëÿ Assandra
Assandra Assandra âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 05.08.2009
Ãîðîä: Êèåâ
Ñîîáùåíèé: 2,044
Ñêàçàë(à) ñïàñèáî: 17
Ïîáëàãîäàðèëè 665 ðàç(à) çà 643 ñîîáùåíèé
Assandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Fantique Ïîñìîòðåòü ñîîáùåíèå
Ring study èëè ring trial - ìåòîä èññëåäîâàíèÿ òî÷íîñòè (ïðàâèëüíîñòè è ïðåöèçèîííîñòè) èçìåðåíèÿ êàêîãî-ëèáî ïàðàìåòðà ïóò¸ì îïðåäåëåíèÿ ïîâòîðÿåìîñòè è âîñïðîèçâîäèìîñòè (repeatability and reproducibility, R&R) èçìåðåíèÿ â ðàçíûõ óñëîâèÿõ (â ïðèìåíåíèè ê ìåäèöèíå - â ðàçíûõ ëàáîðàòîðèÿõ)... ðóññêîì ïåðåâîäå ÷àùå âñåãî íå çàìîðà÷èâàþòñÿ è ïèøóò "êîëüöåâîå èññëåäîâàíèå".
Ìåæëàáîðàòîðíûå ñðàâíåíèÿ (ñëè÷åíèÿ) ðåçóëüòàòîâ.

ÏÑ. Ïðîïóñòèëà ýòîò ïîñò â ñâîå âðåìÿ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #503  
Ñòàðûé 18.03.2014, 12:05
Àâàòàð äëÿ Assandra
Assandra Assandra âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 05.08.2009
Ãîðîä: Êèåâ
Ñîîáùåíèé: 2,044
Ñêàçàë(à) ñïàñèáî: 17
Ïîáëàãîäàðèëè 665 ðàç(à) çà 643 ñîîáùåíèé
Assandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Iera Ïîñìîòðåòü ñîîáùåíèå
Ìíîãî òåðìèíîâ ïî ãåíåòèêå ïîýòîìó íå î÷åíü ïîíÿòíî. Áóäó áëàãîäàðíà çà ïîìîùü!

Using hybridization probes designed to capture a 6 Mb region flanking CYP21A2, targeted massively parallel sequencing (MPS) was performed to analyze genomic DNA samples from parents and proband to determine parental haplotypes. Plasma DNA from pregnant mothers also underwent targeted MPS to deduce fetal inheritance of parental haplotypes.
Âàñ èíòåðåñóþò èìåííî ìîëåêóëÿðíûå ïîäðîáíîñòè?
Îòâåòèòü ñ öèòèðîâàíèåì
  #504  
Ñòàðûé 18.03.2014, 17:43
Iera Iera âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 28.01.2010
Ãîðîä: Áàêó
Ñîîáùåíèé: 226
Ñêàçàë(à) ñïàñèáî: 45
Ïîáëàãîäàðèëè 9 ðàç(à) çà 4 ñîîáùåíèé
Iera ýòîò ó÷àñòíèê èìååò õîðîøóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Assandra Ïîñìîòðåòü ñîîáùåíèå
Âàñ èíòåðåñóþò èìåííî ìîëåêóëÿðíûå ïîäðîáíîñòè?
Äà. Ïðîñòî íåïîíÿòíî êàê è ÷òî îíè äåëàëè.
Îòâåòèòü ñ öèòèðîâàíèåì
  #505  
Ñòàðûé 18.03.2014, 18:00
Àâàòàð äëÿ Assandra
Assandra Assandra âíå ôîðóìà ÂÐÀ×
Âåòåðàí ôîðóìà
      
 
Ðåãèñòðàöèÿ: 05.08.2009
Ãîðîä: Êèåâ
Ñîîáùåíèé: 2,044
Ñêàçàë(à) ñïàñèáî: 17
Ïîáëàãîäàðèëè 665 ðàç(à) çà 643 ñîîáùåíèé
Assandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåAssandra ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïîïðîáóþ ïðèãëàñèòü íàøåãî çàìå÷àòåëüíîãî ìîëåêóëÿðíîãî áèîëîãà.
Îòâåòèòü ñ öèòèðîâàíèåì
  #506  
Ñòàðûé 19.03.2014, 09:18
Claudia812 Claudia812 âíå ôîðóìà
Ìîëåêóëÿðíûé ãåíåòèê
 
Ðåãèñòðàöèÿ: 04.08.2010
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 885
Ñêàçàë(à) ñïàñèáî: 148
Ïîáëàãîäàðèëè 262 ðàç(à) çà 247 ñîîáùåíèé
Claudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ìîëåêóëÿðíûé áèîëîã ñ óòðà äî íî÷è íà Ìîëåêóëÿðíîé äèàãíîñòèêå â Êîñìîñå. Âïå÷àòëåíèé ìîðå! Ðåêîìåíäóþ!
Ñìîãó ïîìî÷ü ñ ïåðåâîäîì â ïò. Íàäåþñü, áóäåò åùå àêòóàëüíî ))
Îòâåòèòü ñ öèòèðîâàíèåì
  #507  
Ñòàðûé 19.03.2014, 11:16
Iera Iera âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 28.01.2010
Ãîðîä: Áàêó
Ñîîáùåíèé: 226
Ñêàçàë(à) ñïàñèáî: 45
Ïîáëàãîäàðèëè 9 ðàç(à) çà 4 ñîîáùåíèé
Iera ýòîò ó÷àñòíèê èìååò õîðîøóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò Claudia812 Ïîñìîòðåòü ñîîáùåíèå
Ìîëåêóëÿðíûé áèîëîã ñ óòðà äî íî÷è íà Ìîëåêóëÿðíîé äèàãíîñòèêå â Êîñìîñå. Âïå÷àòëåíèé ìîðå! Ðåêîìåíäóþ!
Ñìîãó ïîìî÷ü ñ ïåðåâîäîì â ïò. Íàäåþñü, áóäåò åùå àêòóàëüíî ))
Áóäó æäàòü)) Àêòóàëüíî åùå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #508  
Ñòàðûé 21.03.2014, 11:18
Claudia812 Claudia812 âíå ôîðóìà
Ìîëåêóëÿðíûé ãåíåòèê
 
Ðåãèñòðàöèÿ: 04.08.2010
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 885
Ñêàçàë(à) ñïàñèáî: 148
Ïîáëàãîäàðèëè 262 ðàç(à) çà 247 ñîîáùåíèé
Claudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïðèìåðíî òàê:

Äëÿ îïðåäåëåíèÿ ðîäèòåëüñêèõ ãàïëîòèïîâ áûëî ïðîâåäåíî òàðãåòíîå (èëè íàïðàâëåííîå, êàê áîëüøå íðàâèòñÿ) ìàññîâîå ïàðàëëåëüíîå ñåêâåíèðîâàíèå ãåíîìíûõ ÄÍÊ ðîäèòåëåé è ïðîáàíäîâ ñ èñïîëüçîâàíèåì ãèáðèäèçàöèîííûõ çîíäîâ ê îáëàñòè ðàçìåðîì 6 ìåãàáàç, ôëàíêèðóþùåé ãåí CYP21A2. ÄÍÊ ïëàçìû êðîâè áåðåìåííûõ ìàòåðåé òàêæå áûëà ïîäâåðãíóòà íàïðàâëåííîìó ÌÏÑ ñ öåëüþ ïðîñëåäèòü íàñëåäîâàíèå ðîäèòåëüñêèõ ãàïëîòèïîâ ó ïëîäîâ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #509  
Ñòàðûé 21.03.2014, 12:46
Shahla Shahla âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 10.04.2008
Ãîðîä: Áàêó
Ñîîáùåíèé: 1,732
Ïîáëàãîäàðèëè 460 ðàç(à) çà 445 ñîîáùåíèé
Shahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåShahla ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
òàðãåòíîå (èëè íàïðàâëåííîå)
öåëåâîå ïîäîéäåò?
__________________
Èñðàôèëîâà Øàõëà Þñèôîâíà.
Òåðàïåâò, ïóëüìîíîëîã.
Îòâåòèòü ñ öèòèðîâàíèåì
  #510  
Ñòàðûé 21.03.2014, 14:03
Claudia812 Claudia812 âíå ôîðóìà
Ìîëåêóëÿðíûé ãåíåòèê
 
Ðåãèñòðàöèÿ: 04.08.2010
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 885
Ñêàçàë(à) ñïàñèáî: 148
Ïîáëàãîäàðèëè 262 ðàç(à) çà 247 ñîîáùåíèé
Claudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåClaudia812 ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Äóìàþ, è "öåëåâîå" ïîäîéäåò.
NGS íàñòîëüêî ðåäêî îáñóæäàþò ïî-ðóññêè, ÷òî ìîæíî íå áîÿòüñÿ îøèáèòüñÿ ñî ñëîæèâøèìñÿ òåðìèíîì )
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 04:53.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.